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Abstract
Introduction:  Patients  submitted  to  radiotherapy  for  the  treatment  of  head  and  neck  cancer
have several  symptoms,  predominantly  oral.  The  Vanderbilt  Head  and  Neck  Symptom  Survey
version 2.0  is  an  American  tool  developed  to  evaluate  oral  symptoms  in  head  and  neck  cancer
patients  submitted  to  radiotherapy.
Objective:  The  aim  of  the  present  study  was  to  translate  the  Vanderbilt  Head  and  Neck  Symptom
Survey version  2.0  into  Brazilian  Portuguese  and  cross-culturally  adapt  this  tool  for  subsequent
validation and  application  in  Brazil.
Methods:  A  method  used  for  the  translation  and  cultural  adaptation  of  tools,  which  included
independent  translations,  synthesis  of  the  translations,  back-translations,  expert  committee,
and pre-test,  was  used.  The  pre-test  was  performed  with  37  head  and  neck  cancer  patients,
who were  divided  into  four  groups,  to  assess  the  relevance  and  understanding  of  the  assessed
items. Data  were  submitted  to  descriptive  statistical  analysis.
 Please cite this article as: Barroso EM, Carvalho AL, Paiva CE, Nunes JS, Paiva BSR. Translation and cross-cultural adaptation into Brazilian
ortuguese of the Vanderbilt Head and Neck Symptom Survey version 2.0 (VHNSS 2.0) for the assessment of oral symptoms in head and neck
ancer patients submitted to radiotherapy. Braz J Otorhinolaryngol. 2015;81:622--9.
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Vanderbilt  Head  and  Neck  Symptom  Survey  (VHNSS  2.0)  Brazilian  Portuguese  version  623
Results:  The  overall  mean  of  the  content  validity  index  was  0.79  for  semantic  and  idiomatic
equivalence,  and  it  was  higher  than  0.8  for  cultural  and  conceptual  equivalence.  The  cogni-
tive interview  showed  that  patients  were  able  to  paraphrase  the  items,  and  considered  them
relevant and  easily  understood.
Conclusion:  The  tool  was  translated  and  cross-culturally  adapted  to  be  used  in  Brazil.  The
authors believe  this  translation  is  suited  for  validation.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Published  by
Elsevier Editora  Ltda.  All  rights  reserved.
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Traduc¸ão  e  adaptac¸ão  cultural  para  o  português  (Brasil)  do  instrumento  Vanderbilt
Head  and  Neck  Symptom  Survey  version  2.0  (VHNSS  2.0)  para  avaliac¸ão  de  sintomas
orais  em  pacientes  com  câncer  de  cabec¸a e  pescoc¸o submetidos  à  radioterapia
Resumo
Introduc¸ão:  Pacientes  submetidos  à  radioterapia  para  tratamento  de  câncer  de  cabec¸a  e
pescoc¸o apresentam  diversos  sintomas,  com  predominância  de  sintomas  orais.  O  Vanderbilt
Head and  Neck  Symptom  Survey  version  2.0  é  um  instrumento  americano  que  foi  desenvolvido
para avaliar  sintomas  orais  em  pacientes  com  câncer  de  cabec¸a  e  pescoc¸o  submetidos  à  radioter-
apia.
Objetivo:  Traduzir  o  Vanderbilt  Head  and  Neck  Symptom  Survey  version  2.0  e  adaptá-lo  cul-
turalmente  para  subsequente  validac¸ão  e  aplicac¸ão  no  Brasil.
Método:  Um  método  de  traduc¸ão  e  adaptac¸ão  cultural  de  instrumentos  foi  utilizado,  o  qual
inclui traduc¸ões  independentes,  síntese  das  traduc¸ões,  retrotraduc¸ões,  comitê  de  especialistas
e pré-teste.  O  pré-teste  foi  realizado  em  37  pacientes  com  câncer  de  cabec¸a  e  pescoc¸o  divididos
em quatro  grupos  para  avaliar  a  relevância  e  entendimento  dos  itens.  Dados  foram  submetidos
à análise  estatística  descritiva.
Resultados:  A  média  geral  do  índice  de  validade  de  conteúdo  foi  0,79  para  as  equivalên-
cias semânticas  e  idiomáticas;  e  maior  que  0,8  para  as  equivalências  cultural  e  conceitual.
A entrevista  cognitiva  mostrou  que  os  pacientes  foram  capazes  de  parafrasear  os  itens  e  os
consideravam  relevante  e  de  fácil  entendimento.
Conclusão:  O  instrumento  foi  traduzido  e  adaptado  culturalmente  ao  Brasil.  Nós  acreditamos
que esta  traduc¸ão  está  apta  para  a  validac¸ão.
© 2015  Associac¸ão  Brasileira  de  Otorrinolaringologia  e  Cirurgia  Cérvico-Facial.  Publicado  por
Elsevier Editora  Ltda.  Todos  os  direitos  reservados.
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Head  and  neck  cancer  (HNC)  includes  tumors  that  affect
the  lips,  oral  cavity,  oropharynx,  nasopharynx,  hypopharynx,
larynx,  nasal  cavity  and  paranasal  sinuses,  thyroid  gland,
and  salivary  glands.1 These  cancers  account  for  approxi-
mately  10%  of  malignant  tumors.2 In  Brazil,  for  the  years
2012/2013,  approximately  20,000  cases  were  estimated  only
for  tumors  in  the  oral  cavity  and  larynx.3
Therapeutic  options  for  HNC,  including  radiotherapy,
contribute  to  signiﬁcant  adverse  symptoms  and  loss  of
function.4 Such  symptoms  may  occur  immediately,  soon
after  the  treatment,  or  may  appear  later.5 The  oral  alter-
ations  are  prominent,  and  include  mucositis,  dysphagia,
taste  and  mucosal  sensitivity  alterations,  xerostomia,  teeth
alterations,  and  excess  mucus.5--9 With  the  exception  of
xerostomia,  mucositis,  and  dysphagia,  these  alterations
have  been  little  discussed  in  the  literature  and  are  believed
to  be  underreported.9 Half  of  surviving  HNC  patients  have
problems  and  complications  ﬁve  years  after  the  primary
treatment,  which  include  pain,  problems  with  teeth,
i
s
iroblems  with  chewing  and  swallowing,10 or  high  scores
or  symptoms  such  as  xerostomia,  mucus  production,  and
wallowing  alterations  related  to  treatment.11
The  xerostomia  resulting  from  HNC  treatment  causes
amage  to  oral  health12 and  has  a  negative  impact  on
he  quality  of  life  (QoL)  of  these  patients.6 In  addition  to
yposalivation,  which  contributes  to  the  onset  of  mucositis,
ome  patients  may  have  an  excessive  amount  of  mucus11
hat  obstructs  the  airway,  resulting  in  alterations  in  sleep-
ng,  coughing,  and  choking.9 Another  common  symptom  in
atients  treated  for  HNC  is  the  alteration  of  taste,8 a  direct
esult  of  the  effect  of  radiation  on  the  taste  buds,  and
lterations  in  saliva.13 HNC  treatment  also  contributes  to  a
orsening  of  dental  health.14 Patients  submitted  to  radio-
herapy  had  worse  dental  status  when  compared  to  those
ubmitted  to  chemotherapy.15 In  the  Brazilian  population,  a
ongitudinal  study  showed  that  in  patients  with  oral  cancer,
he  most  common  problems  were  related  to  difﬁculties
n  chewing,  swallowing,  pain,  and  reduced  salivary  ﬂow,
uggesting  the  importance  of  dental  monitoring  of  patients
n  all  stages  of  treatment.16
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Some  of  the  toxicities  associated  with  treatment  for
atients  with  HNC  can  be  minimized,  but  are  inevitable,
ighlighting  the  importance  of  identifying  and  controlling
dverse  effects  related  to  treatment  by  the  health  team.8
he  tools  to  identify  and  evaluate  these  alterations  resulting
rom  the  treatment  can  serve  as  diagnostic  tools,  helping  to
stablish  the  most  appropriate  conduct  for  the  care  plan  of
hese  patients.
Symptom  assessment  is  often  considered  within  the
hysical  and  functional  domains  of  QoL  evaluation  question-
aires,  so  there  is  some  difﬁculty  in  differentiating  symptom
esearch  tools  from  QoL  assessment.17 In  patients  with  HNC,
he  most  used  and  validated  tools  in  Brazil  to  assess  QOL
re  the  University  of  Washington  QOL  (UW-QOL),18 the  FACIT-
N,19 and  the  EORTC-HN35,20 whereas  for  symptom  research
n  HNC  it  is  the  MDASI-HN.21 Overall,  the  tools  used  for  QOL
ssessment  comprise  problems  such  as  dysphagia,  xeros-
omia,  and  mucositis.  However,  they  fail  to  report  oral
ymptoms  such  as  mucosal  sensitivity,  excess  mucus,  dental
roblems,  and  their  functional  implications.  The  Vanderbilt
ead  and  Neck  Symptom  Survey  (VHNSS)  2.09,22,23 is  an  Amer-
can  symptom  assessment  tool  speciﬁcally  used  in  patients
ith  HNC  whose  treatment  includes  radiotherapy  that  more
roadly  assesses  oral  health  components,  with  a  speciﬁc
omain  for  dental  health  and  its  functional  implications.
t  contains  50  items  distributed  into  13  domains:  nutrition,
wallowing/food  intake,  xerostomia,  mucositis,  pain,  excess
ucus,  speech/communication,  hearing,  taste  and  smell
lterations,  dental  health,  mucosal  sensitivity,  and  range
f  motion.  The  answer  options  are  graded  on  a  scale  of
--10,  so  that  zero  (0)  signiﬁes  no  problem  and  ten  (10)  is
he  maximum  presence  of  a  speciﬁc  problem.  The  reliability
easured  by  Cronbach’s  ˛  is  suitable,  ranging  from  0.70  to
.94.22 Therefore,  the  VHNSS  2.0  was  selected  for  transla-
ion  and  cross-cultural  adaptation  into  Brazilian  Portuguese.
ethodshis  was  a  descriptive,  cross-sectional  study,  using  a  method
f  translation  and  cross-cultural  adaptation  of  the  assess-
ent  tool,  performed  in  the  following  ﬁve  steps:
t
i
o
v
Translator 1
Translator 2
Translator 3
VHNSS 2.0
Pre-test
32 patients
Version T4 Expert comm
Version T
igure  1  Methodological  steps  used  in  the  translation  and  cross-c
urvey (VHNSS)  version  2.0.Barroso  EM  et  al.
Translation  and  cross-cultural  adaptation  process:  The
rocess  of  translation  and  cross-cultural  adaptation  of
he  VHNSS  2.0  into  Brazilian  Portuguese  was  performed
ccording  to  the  international  guidelines.24,25 Consent  and
uthorization  in  writing  was  obtained  via  email  from  the
uthor  of  the  original  tool,  Dr.  Barbara  A.  Murphy,  and  the
tudy  was  approved  by  the  Research  Ethics  Committee  (pro-
ocol  No.  644/2012).  Fig.  1  summarizes  the  steps  of  the
ranslation  and  cross-cultural  adaptation  process.
Translation: Carried  out  by  three  native  Brazilian  individ-
als  ﬂuent  in  English,  of  whom  two  were  from  the  healthcare
rea  (physicians),  whereas  the  third  translator  was  not.
Synthesis  of  translations: The  three  translated  versions
ere  synthesized  into  a  single  version  (T123),  in  a  consensus
eeting  attended  by  three  of  the  authors  (EMB,  CEP,  and
SRP).
Back  translation: Performed  by  American  Journal
xperts,  a  company  specialized  in  translations,  which
eceived  and  complied  with  the  guidelines  that  the  two
ack-translators  should  be  native  American  English  speak-
rs  and  should  be  unaware  of  the  original  version.  The  back
ranslations  were  evaluated  and  forwarded  to  the  author  of
he  original  tool.
Expert  Committee: The  versions  were  evaluated  by  an
xpert  committee  in  the  ﬁeld  of  health  assessment  tools,
onsisting  of  a  head-and-neck  oncology  surgeon,  two  clin-
cal  oncologists,  one  nurse,  one  dentist,  and  a  university
rofessor  of  linguistics.  The  aim  of  the  committee  was
o  assess  the  translated  version  and  compare  it  to  the
riginal  one,  regarding  semantic,  idiomatic,  cultural,  and
onceptual  equivalence,  scoring  ‘‘1’’  (one)  for  the  equiv-
lent  items,  ‘‘0’’  (zero)  for  the  items  they  did  not  know,
nd  ‘‘−1’’  (minus  one)  for  the  non-equivalent  items.  They
lso  had  autonomy  to  suggest  cultural  changes  they  deemed
mportant.  The  equivalence  calculation  was  made  using  the
ean  of  the  items  of  the  content  validity  index  (CVI)  for
ach  one  of  them,  considered  equivalent  when  >0.8.26 Addi-
ionally,  the  suggestions  made  by  the  committee  were  taken
nto  consideration,  discussed  at  a  meeting  attended  by  four
f  the  authors  (EMB,  CEP,  BSRP,  JSN),  which  yielded  a  new
ersion  (T4).
Synthesis of
the translation Version T123
Back-translator 1
Back-translator 2
Pre-test
5 patients
ittee
5
Final version
VHNSS 2.0
ultural  adaptation  of  the  Vanderbilt  Head  and  Neck  Symptom
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Table  1  Modiﬁcations  suggested  for  VHNSS  2.0  items  by  the  expert  committee  and  translators.
Item  Original  version  Adapted  version  Justiﬁcation
Title Survey  (pesquisa) Questionnaire  (questionário)  More  adequate  word  for  the
Brazilian  culture
1st Instruction  Appropriate  Box  (caixa
apropriada)
Chosen  option  (opc¸ão  escolhida)  Clearer  and  more  informal
1 I  currently  have  a  feeding  tube
in  place
(Eu  atualmente  tenho  um  tubo
de  alimentac¸ão  colocado)
Are  you  using  a  tube  to  be  fed?
(Você  está  usando  uma  sonda
para  se  alimentar?)
Clearer  and  more  informal
2nd Instruction .  .  .In  general,  a  ‘‘0’’  indicates
the least  amount  of  problems
with  a  particular  symptom  and
‘‘10’’  indicates  the  most
problems.  (Em  geral  ‘‘0’’  indica
a menor  quantidade  de  problema
com  sintoma  particular  e  ‘‘10’’
indica  o  maior  dos  problemas)
In  general  ‘‘0’’  indicates  the
absence  of  a  symptom  (problem)
and  ‘‘10’’  indicates  the
maximum  presence  of  symptom
(problem)  (Em  geral,  ‘‘0’’  indica
a ausência  de  um  sintoma
(problema)  e  ‘‘10’’  indica  a
presenc¸a  máxima  de  um  sintoma
(problema)
The  substitution  of  the  term
‘‘amount’’  by  ‘‘presence’’
makes  the  sentence  most
objective
3 ‘‘like  EnsureTM or  BoostTM’’
(como  EnsureTM or  BoostTM’’)  e
Liquid  Supplement
(suplemento  líquido)
‘‘like  EnsureTM,  NutrenTM,
SustagemTM’’  (como  EnsureTM,
NutrenTM,  SustagemTM)
Dietary  liquid  supplement
(suplemento  alimentar  liquido)
Products  available  in  Brazil.
Dietary  liquid  supplement  was
added,  as  it  is  known  in  Brazil
5 Trouble  (problema)  Difﬁculty  (diﬁculdade)  Adaptation  to  item  4
6 Trouble  (problema)  Difﬁculty  (diﬁculdade).
Removal  of  the  word  thin  (ralos)
and Ensure,  substituted  by  juice
(sucos)
Removal  of  the  word  thin,  which
is not  commonly  used  in  Brazil
and substitution  of  Ensure  by
juice,  a  typical  Brazilian  drink
15 Swallowing  (deglutic¸ão)  Swallow  (engolir)  More  informal  translation  of
deglutition
16 Ability  to  sleep  (capacidade  de
dormir)
Sleep  (sono)  Makes  the  item  more  objective
17 Ability  to  talk
(capacidade  de  falar)
Talk  (falar)  Makes  the  item  more  objective
18, 19,  20,  21  Mucous  (muco)  Secretion  (secrec¸ão)  More  informal  word
27 Average  (média)  Remoc¸ão  da  palavra  average
(média)
Makes  the  item  more  objective
32 Hearing  (audic¸ão)  Hear  (ouvir)  More  informal  word,  culturally
appropriate
34 I  have  less  desire  to  eat  (Eu
tenho  menos  desejo  de  comer)
You  feel  less  like  eating  (Você
sente  menos  vontade  de  comer)
More  informal  word,  culturally
appropriate
37, 38  An  explanatory  parenthesis  on
ability  to  smell  (capacidade  de
sentir  cheiro)  was  added
Facilitates  understanding
39, 40,  41,  42  Non  applicable  (não  aplicável)  Cannot  be  applied  (não  se
aplica).
Facilitates  understanding
44, 45,  46,  47,  48 Remoc¸ão  da  palavra  lining
(mucosa)
Technical  word  of  difﬁcult
understanding,  culturally
appropriate
48 The  expression  ‘‘Cannot  be
applied’’  (não  se  aplica)  was
added.
Because  eventually  someone
might  not  have  any  teeth  and
the item  does  not  apply
49 Limitations  in  the  ability
(limitac¸ão  na  capacidade)  and
jaw  (mandíbula)
Difﬁculy  (diﬁculdade)  and
mouth  (boca)
Word  of  difﬁcult  understanding,
culturally  appropriate
50 Limitations  in  the  ability
(limitac¸ão  na  capacidade)
Difﬁculy  (diﬁculdade)  Culturally  adequate
VHNSS 2.0, Vanderbilt Head and Neck Cancer Symptom Survey version 2.0.
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Table  2  Modiﬁcations  suggested  for  the  answers  to  VHNSS  2.0  by  the  committee  of  experts  and  translators.
Answers  to  items  Original  version  Adapted  version  Justiﬁcation
22  No  pain/severe
pain  (Nehuma
dor/Dor  intensa)
Never/Always  (Nunca/Sempre)  The  item  refers  to  the  fact  of  having  or  not
lesions  and  not  the  intensity  of  pain.  The  answer
was adequate  to  the  question
32, 39  None/Severe
(Nenhum/Grave)
None/A  lot  (Nenhum/Muito)  The  word  ‘‘grave’’  would  not  be  appropriate  in
this context,  culturally  adequate
42 Not  at  all/Severe
(Nenhum/Grave)
None/A  lot  (Nenhum/Muito)  The  word  ‘‘grave’’  would  not  be  appropriate  in
this context,  culturally  adequate
14,49,50 Never/Severe
(Nunca/Grave)
Never/Always  (Nunca/Sempre)  Answers  mixed  the  concepts  of  frequency  and
intensity.  It  was  decided  to  maintain  only  the
frequency  concept
sion 2.0.
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Table  3  Mean  of  the  CVI  of  the  items.
Equivalence  CVI  of  items  CVI  of  answers
to  items
Semantic/idiomatic  0.79  0.96
Cultural  0.86  0.98
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re-test
n  order  to  assess  the  clarity  and  understanding  of  the
4  version,  a  pilot  test  was  performed,  which  included
atients  with  HNC  (oral  cavity,  larynx,  oropharynx,  and/or
ypopharynx)  had  been  submitted  to  oncologic  treatment,
ncluding  radiotherapy,  for  more  than  six  months  previ-
usly  and  who  agreed  to  participate  by  signing  the  informed
onsent.  Patients  with  cognitive  or  mental  impairment
hat  prevented  them  from  providing  correct  information
ere  excluded.  Sociodemographic  information  was  obtained
hrough  an  interview  and  clinical  data  from  medical  records.
he  32  patients  who  met  the  inclusion  criteria  were  divided
nto  four  groups  based  on  domains,27 with  the  ﬁrst  group
valuating  items  1--17,  the  second  group  items  18--31,
he  third  group  items  32--43,  and  the  fourth  group  items
4--50.  Patients  answered  a  structured  interview  individu-
lly  to  assess  the  importance  and  understanding  of  items  and
nswers,  whether  they  would  ask  the  question  differently,
nd  the  meaning  of  the  item,27 thus  ensuring  that  each  item
as  adequate  and  understood  by  the  patients.  Furthermore,
ve  patients  were  enrolled  at  this  stage  to  test  the  cultural
daptations  of  six  items  (5,  10,  14,  27,  38,  43),  as  the  ques-
ion  related  to  the  meaning  showed  they  were  not  clear  for
hese  patients.
tatistical  analysis
ata  are  shown  through  descriptive  statistics  for  sociodemo-
raphic  and  clinical  characteristics,  as  well  as  for  the  CVI,
sing  SPSS  v.  20  software.
esults
he  process  of  translation  and  cross-cultural  adaptation  of
he  VHNSS  2.0  tool  into  the  Brazilian  Portuguese  language  is
escribed  below.  It  is  noteworthy  that  the  back-translation
rocess  showed  that  the  initial  version  in  Portuguese  corre-
ponded  to  the  English  version.  The  suggestions  given  by  the
xpert  committee  were  discussed  and  incorporated  into  the
ool  in  order  to  adapt  it  to  Brazilian  culture.Tables  1  and  2  describe  the  main  cultural  adjustments
ithin  the  items  and  tool  responses.  The  main  alteration
as  the  person:  in  the  original  tool,  all  items  are  in  the  1st
erson  singular,  whereas  the  translated  version  was  adapted
rConceptual  0.89  0.98
CVI, content validity index.
o  the  2nd  person  singular  to  provide  more  clarity  and  allow
he  tool  to  be  both  self-applied,  as  well  as  to  be  applied  by
n  interviewer.
The  CVI,  which  was  calculated  as  the  mean  of  the  items
or  each  equivalence  given  by  the  raters,  was  0.79  for
diomatic  and  semantic  equivalence  of  the  items  and  >0.8
or  the  other  equivalences  (Table  3).
re-test  interview
 total  of  37  patients  participated  in  this  stage,  with  a
edian  age  of  60  years,  of  whom  32  (86.5%)  were  males,
1  (56.8%)  Caucasians,  27  (73%)  married,  26  (70.3%)  were
arely  literate  or  had  not  ﬁnished  elementary  school,  23
62.2%)  were  from  the  state  of  São  Paulo,  31  (84%)  were
rofessionally  inactive,  eight  (21.6%)  were  current  smok-
rs  and  27  (73%)  ex-smokers,  two  (5.4%)  consumed  alcohol
nd  21  were  ex-alcohol  drinkers  (56.8%),  29  (78.5%)  were
atholics,  and  24  (65%)  had  no  associated  comorbidity.  The
linical  characteristics  are  described  in  Table  4.
At  the  ﬁrst  moment,  32  patients  participated  in  the
re-test  and  were  divided  by  domain  and  age,  answer-
ng  questions  related  to  the  understanding  of  the  items,
ith  each  group  containing  eight  patients,  equally  divided
etween  those  aged  up  to  60  years  old  or  older.  The  patients
onsidered  the  items  important,  easily  understood,  and
ere  able  to  understand  the  answers.  In  six  items  (5,  10,
4,  27,  38,  43)  with  the  question  ‘‘Could  you  tell  me  in
our  own  words  what  it  means  for  you?’’,  25%  of  patients
nderstood  incorrectly.  Therefore,  these  were  discussed  at
 consensus  meeting  and  based  on  the  comments,  they  were
eformulated  as  follows:
Items  5 and  10:  removal  of  the  word  ‘‘solid’’,  as  patients
did  not  understand  what  solid  was.
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Table  4  Clinical  characteristics  of  patients  participating  in
the pre-test.
Variable  Frequency  (n)  Percentage  (%)
Histological  type
SCC  37  100.0
TNM
I 3  8.1
II 2  5.4
III 15  40.5
IV 16  43.2
‘‘Missing’’  1  2.7
Location
Oral cavity  6  16.2
Hypopharynx  4  10.8
Oropharynx  13  35.1
Larynx 13  35.1
Oral cavity  and  larynx  1  2.7
Surgery
Yes 21  56.8
No 16  43.2
Lymphadenectomy
No 6  31.6
Yes 13  68.4
Chemotherapy
No 11  29.7
Yes 26  70.3
ECOG
0 26  70.3
1 11  29.7
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(TNM, classiﬁcation of malignant tumors; ECOG, Eastern Cooper-
ative Oncology Group.
Item  14:  substituting  the  word  ‘‘problem’’  with  ‘‘feeling,’’
as  they  considered  the  dry  mouth  a  feeling  and  not  a prob-
lem.
Item  38:  change  of  the  order  of  words  in  the  sentence  to
make  it  more  direct.
Items  27  (‘‘The  relief  of  your  pain  with  analgesics  had
been:  Not  applicable,  since  I  do  not  use  analgesics’’)  and  43
(‘‘Have  you  had  problems  with  your  dentures?  Not  applica-
ble,  because  I do  not  wear  dentures’’)  were  not  changed,
because  the  authors  that  participated  in  the  consensus
meeting  (EMB,  CEP,  BSRP)  considered  that  the  suggestions
made  by  patients  to  these  two  items  did  not  add  relevant
information.  These  items  were  reapplied  to  ﬁve  patients  to
conﬁrm  that  the  changes  were  appropriate.  Therefore,  the
process  of  translation  and  cross-cultural  adaptation  ended,
resulting  in  the  Brazilian  Portuguese  version  of  the  VHNSS
2.0  tool,  which  in  Brazil  is  known  as  the  ‘‘Questionário  de
sintomas  em  Câncer  de  Cabec¸a e  Pescoc¸o de  Vanderbilt’’
(VHNSS  2.0).
DiscussionThe  method  used  in  this  study  allowed  the  translation  and
cross-cultural  adaptation  of  the  VHNSS  2.0  tool  to  the  Brazil-
ian  culture  and  will  allow  its  use  in  the  assessment  of  oral
u
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ymptoms  related  to  treatment  that  includes  radiotherapy
f  patients  with  HNC  and  their  functional  implications.  It  is
orth  mentioning  that  this  is  the  ﬁrst  tool  in  Brazilian  Por-
uguese  that  includes  a  domain  that  evaluates  the  dental
tatus  in  this  population.
During  the  process  of  cross-cultural  adaptation  of  the
ool,  the  change  from  the  ﬁrst  to  the  second  person  sin-
ular  resulted  in  a  tool  that  can  be  self-applied  or  applied
y  an  interviewer,  as  a  previous  validation  study  in  Brazil
howed  that  77%  of  Brazilians  prefer  assessment  tools  to
e  applied  by  interviewers,  with  the  given  reasons  being
ainly  personal  preference  and  difﬁculty  reading.28 Addi-
ionally,  the  inﬂuence  of  social  and  educational  levels  on
NC  incidence  must  be  considered.  A  meta-analysis  study
f  41  articles  evaluated  the  association  between  oral  can-
er  and  socioeconomic  status,  and  found  that  individuals  of
ow  socioeconomic  status,  including  low  educational  level,
ower  income,  and  lower  occupational  class,  are  more  likely
o  have  the  disease.29
In  Brazil,  the  incidence  of  HNC  is  2.5  higher  in  individuals
ho  have  low  educational  level.30 A  study  carried  out  in  São
aulo  found  that  45.4%  and  43.6%  of  patients  with  HNC  were
lliterate  or  had  not  ﬁnished  elementary  school  in  the  years
000  and  2006,  respectively.31 Therefore,  a  tool  that  can  also
e  applied  by  an  interviewer  meets  this  population’s  needs,
hich  in  this  study  comprised  the  70.3%  of  patients  who  were
arely  literate  or  had  not  ﬁnished  elementary  school,  with
 median  income  of  one  minimum  wage.
The  reason  that  led  to  the  translation  and  cross-cultural
daptation  of  a  new  tool  was  primarily  the  fact  that  the
vailable  tools  in  Brazil  that  evaluate  symptoms  related
o  treatment  in  patients  with  HNC  are  associated  with
ools  that  assess  health-related  QoL,  and  do  not  include  a
omplete  assessment  of  dental  and  oral  health  and  their
unctional  implications.  It  is  noteworthy  that  a  detailed
ral  health  assessment  is  important,  since  patients  treated
or  HNC,  including  radiation  therapy,  often  have  oral  alter-
tions.  Additionally,  it  must  be  considered  that  developing
ew  tools  takes  time  and  costs  money.32
Symptoms  such  as  dysphagia  and  xerostomia  have  a  nega-
ive  impact  on  health-related  QoL.6 Xerostomia  is  a  frequent
nd  important  symptom,  reported  by  52%  of  patients  treated
or  oral  and  oropharyngeal  cancer;  moreover,  the  functional
utcome  measured  by  the  Mandibular  Function  Impairment
uestionnaire  (MFIQ)  is  inﬂuenced  by  the  incapacity  to  wear
ental  prostheses.33 It  is  noteworthy  that  40.7%  of  individ-
als  reported  chewing  difﬁculties  attributed  to  their  teeth
r  dentures,  50%  reported  that  their  teeth  are  sensitive  to
eat,  cold,  or  sweets,  and  36%  said  they  had  frail  or  chipped
eeth.9
Murphy  et  al.  reported  that  76%  of  patients  undergo-
ng  chemoradiotherapy  or  radiotherapy  for  HNC  had  severe
ain  in  the  mouth  and  throat,  resulting  in  loss  of  function
nd  increased  use  of  opioids  for  pain  reduction  associated
ith  mucosites.34 Dental  problems  affect  a large  number
f  patients  and  occur  due  to  the  reduction  in  the  salivary
ow  directly  associated  with  alterations  in  dental  structures
enamel,  dentin)  caused  by  radiation.35The  translation  and  cross-cultural  adaptation  method
sed  in  this  study  has  been  consolidated  in  literature.24,25
he  translation  process  involved  individuals  from  the  health
rea,  as  well  as  a  lay  person,  so  that  the  terms  could  be
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128  
ranslated  to  facilitate  the  understanding  by  the  patients
ho  will  answer  the  tool.  The  choice  of  using  the  services
f  a  specialized  company  for  the  back-translation  was  made
o  optimize  the  process  with  professionals  who  are  native
nglish  speakers  and  are  also  ﬂuent  in  Portuguese.  The
ssessment  of  equivalence  by  the  expert  committee  showed
hat  the  Portuguese  version  of  the  VHNSS  2.0  is  equivalent
o  the  English  version.
One  limitation  of  this  study  is  the  small  sample  size
sed  in  the  pre-test  and  the  division  by  domains  of  the
pplied  structured  interviews.  The  low  educational  level  of
he  patients  with  HNC  in  Brazil  may  hinder  the  understanding
f  the  questionnaire,  limiting  its  self-application,  although
he  tool  also  has  been  adapted  to  allow  its  application  by  an
nterviewer.
onclusion
ranslation  and  cultural  adaptation  of  the  VHNSS  2.0  tool
nto  Brazilian  Portuguese  has  been  performed,  providing  an
mportant  tool  to  assess  oral  symptoms  in  patients  with
NC  submitted  to  treatment  that  includes  radiotherapy.  The
esults  demonstrated  that  the  Brazilian  version  of  the  VHNSS
.0  tool  is  equivalent  to  the  original  in  English,  was  easily
nderstood  by  patients,  and  was  also  adapted  to  Brazilian
ulture.  Therefore,  the  tool  is  considered  adequate  for  the
alidation  step,  a  process  that  is  underway.
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